GIVEN DOUGLAS B

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GIVEN DOUGLAS B's trades of Arrowhead Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-18 2024-12-17
PlS Planned sale
55,349 +17.0%
431.18
US$1,206,923 		55,349 +17.0% 431.18 US$1,206,923
2024-12-17 2024-12-17
PrS Proposed sale
38,313
47.01
US$4,593,514 		38,313 47.01 US$4,593,514
2024-12-18 2024-12-16
PlS Planned sale
27,164 -24.8%
189.80
US$834,300 		27,164 -24.8% 189.80 US$834,300
2024-12-16 2024-12-16
PrS Proposed sale
5,000
21.89
US$109,470 		5,000 21.89 US$109,470
2024-01-16 2024-01-11
PlS Planned sale
1,100 -0.8%
38.55
US$42,405 		1,100 -0.8% 38.55 US$42,405
2024-01-16 2024-01-11
PlS Planned sale
1,811 -1.4%
37.76
US$68,383 		1,811 -1.4% 37.76 US$68,383
2024-01-11 2024-01-11
PrS Proposed sale
2,911
36.61
US$106,581 		2,911 36.61 US$106,581
2023-05-08 2023-05-05
S Sale
6,500 -5.2%
40.90
US$265,850 		6,500 -5.2% 40.90 US$265,850
2023-05-05 2023-05-05
PrS Proposed sale
6,500
40.90
US$265,831 		6,500 40.90 US$265,831
2023-03-01 2023-02-27
S Sale
875 -6.3%
32.62
US$28,542 		875 -6.3% 32.62 US$28,542
2021-06-24 2021-06-22
S Sale
4,500 -3.8%
89.21
US$401,445 		4,500 -3.8% 89.21 US$401,445
2021-02-24 2021-02-22
S Sale
1,125 -7.5%
88.73
US$99,821 		1,125 -7.5% 88.73 US$99,821
2021-01-19 2021-01-15
S Sale
3,000 -19.4%
83.28
US$249,840 		3,000 -19.4% 83.28 US$249,840
2021-01-05 2021-01-04
S Sale
4,000 -3.2%
76.08
US$304,320 		4,000 -3.2% 76.08 US$304,320
2020-12-18 2020-12-17
S Sale
500 -3.2%
79.59
US$39,795 		500 -3.2% 79.59 US$39,795
2020-12-18 2020-12-17
S Sale
9,075 -7.3%
79.30
US$719,648 		9,075 -7.3% 79.30 US$719,648
2020-04-16 2020-04-14
S Sale
25,000 -13.8%
36.89
US$922,250 		25,000 -13.8% 36.89 US$922,250
2019-02-26 2019-02-26
S Sale
65,000 -27.1%
19.25
US$1,251,250 		65,000 -27.1% 19.25 US$1,251,250
2019-02-26 2019-02-22
PlS Planned sale
3,000 -1.7%
18.05
US$54,150 		3,000 -1.7% 18.05 US$54,150
2019-01-24 2019-01-22
PlS Planned sale
3,000 -1.7%
13.58
US$40,740 		3,000 -1.7% 13.58 US$40,740